Stock Price
2.14
Daily Change
-0.02 -0.93%
Monthly
-4.89%
Yearly
-92.05%
Q3 Forecast
2.14

Cassava Sciences reported $-45174000 in EBITDA for its fiscal quarter ending in June of 2025.




Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Cassava Sciences USD -45174000 15.95M Jun/2025
Eisai JPY 8.81B 28.8B Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Geron USD -7550000 8.85M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Merck USD 7.74B 625M Mar/2025
Novartis USD 6.17B 339M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024